Cargando…
Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression
Thyroid cancer is common, yet the sequence of alterations that promote tumor formation are incompletely understood. Here, we describe a novel model of thyroid carcinoma in zebrafish that reveals temporal changes due to BRAF(V600E). Through the use of real-time in vivo imaging, we observe disruption...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389860/ https://www.ncbi.nlm.nih.gov/pubmed/28350298 http://dx.doi.org/10.7554/eLife.20728 |
_version_ | 1782521351556300800 |
---|---|
author | Anelli, Viviana Villefranc, Jacques A Chhangawala, Sagar Martinez-McFaline, Raul Riva, Eleonora Nguyen, Anvy Verma, Akanksha Bareja, Rohan Chen, Zhengming Scognamiglio, Theresa Elemento, Olivier Houvras, Yariv |
author_facet | Anelli, Viviana Villefranc, Jacques A Chhangawala, Sagar Martinez-McFaline, Raul Riva, Eleonora Nguyen, Anvy Verma, Akanksha Bareja, Rohan Chen, Zhengming Scognamiglio, Theresa Elemento, Olivier Houvras, Yariv |
author_sort | Anelli, Viviana |
collection | PubMed |
description | Thyroid cancer is common, yet the sequence of alterations that promote tumor formation are incompletely understood. Here, we describe a novel model of thyroid carcinoma in zebrafish that reveals temporal changes due to BRAF(V600E). Through the use of real-time in vivo imaging, we observe disruption in thyroid follicle structure that occurs early in thyroid development. Combinatorial treatment using BRAF and MEK inhibitors reversed the developmental effects induced by BRAF(V600E). Adult zebrafish expressing BRAF(V600E) in thyrocytes developed invasive carcinoma. We identified a gene expression signature from zebrafish thyroid cancer that is predictive of disease-free survival in patients with papillary thyroid cancer. Gene expression studies nominated TWIST2 as a key effector downstream of BRAF. Using CRISPR/Cas9 to genetically inactivate a TWIST2 orthologue, we suppressed the effects of BRAF(V600E) and restored thyroid morphology and hormone synthesis. These data suggest that expression of TWIST2 plays a role in an early step of BRAF(V600E)-mediated transformation. DOI: http://dx.doi.org/10.7554/eLife.20728.001 |
format | Online Article Text |
id | pubmed-5389860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53898602017-04-14 Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression Anelli, Viviana Villefranc, Jacques A Chhangawala, Sagar Martinez-McFaline, Raul Riva, Eleonora Nguyen, Anvy Verma, Akanksha Bareja, Rohan Chen, Zhengming Scognamiglio, Theresa Elemento, Olivier Houvras, Yariv eLife Cancer Biology Thyroid cancer is common, yet the sequence of alterations that promote tumor formation are incompletely understood. Here, we describe a novel model of thyroid carcinoma in zebrafish that reveals temporal changes due to BRAF(V600E). Through the use of real-time in vivo imaging, we observe disruption in thyroid follicle structure that occurs early in thyroid development. Combinatorial treatment using BRAF and MEK inhibitors reversed the developmental effects induced by BRAF(V600E). Adult zebrafish expressing BRAF(V600E) in thyrocytes developed invasive carcinoma. We identified a gene expression signature from zebrafish thyroid cancer that is predictive of disease-free survival in patients with papillary thyroid cancer. Gene expression studies nominated TWIST2 as a key effector downstream of BRAF. Using CRISPR/Cas9 to genetically inactivate a TWIST2 orthologue, we suppressed the effects of BRAF(V600E) and restored thyroid morphology and hormone synthesis. These data suggest that expression of TWIST2 plays a role in an early step of BRAF(V600E)-mediated transformation. DOI: http://dx.doi.org/10.7554/eLife.20728.001 eLife Sciences Publications, Ltd 2017-03-28 /pmc/articles/PMC5389860/ /pubmed/28350298 http://dx.doi.org/10.7554/eLife.20728 Text en © 2017, Anelli et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Anelli, Viviana Villefranc, Jacques A Chhangawala, Sagar Martinez-McFaline, Raul Riva, Eleonora Nguyen, Anvy Verma, Akanksha Bareja, Rohan Chen, Zhengming Scognamiglio, Theresa Elemento, Olivier Houvras, Yariv Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title | Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title_full | Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title_fullStr | Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title_full_unstemmed | Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title_short | Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression |
title_sort | oncogenic braf disrupts thyroid morphogenesis and function via twist expression |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389860/ https://www.ncbi.nlm.nih.gov/pubmed/28350298 http://dx.doi.org/10.7554/eLife.20728 |
work_keys_str_mv | AT anelliviviana oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT villefrancjacquesa oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT chhangawalasagar oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT martinezmcfalineraul oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT rivaeleonora oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT nguyenanvy oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT vermaakanksha oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT barejarohan oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT chenzhengming oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT scognamigliotheresa oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT elementoolivier oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression AT houvrasyariv oncogenicbrafdisruptsthyroidmorphogenesisandfunctionviatwistexpression |